Browse by Cancer Type

NCCN continues to add to the library of chemotherapy order templates to improve the safe use of drugs and biologics in cancer care. NCCN Chemotherapy Order Templates (NCCN Templates®) are intended for personal and practical use only. The information contained in the NCCN Templates is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®). The NCCN Templates include chemotherapy, immunotherapy, supportive care agents, monitoring parameters, and safety instructions. Special instructions for self-administered chemotherapeutic agents are also provided.
NCCN Templates® enhance patient safety by allowing you to:
  • Standardize patient care
  • Reduce medication errors
  • Anticipate and manage adverse events
Exception occured while executing the controller. Check error logs for details.

The NCCN Templates® are copyrighted by the NCCN. All rights reserved. NCCN Templates® are intended for personal and practical use only. NCCN Content may not be reproduced in any form for any purpose without the express written permission of the NCCN.

The NCCN Guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to cancer treatment. The recommendations regarding the uses and indications in the NCCN Compendium have been derived directly from the NCCN Guidelines. The NCCN Compendium represents neither an all-inclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The NCCN Templates are peer reviewed statements of consensus of their authors derived from the NCCN Guidelines for the conditions the NCCN Templates address. The NCCN Templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the NCCN Guidelines or the NCCN Compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer. A NCCN Template does not constitute an order.